As featured in…
Latest Press Releases
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Following Significant Scientific Achievement
Company surpasses $3M in accepted investments CHICAGO – September 16, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, announced it has modified its Regulation A+ (Mini-IPO) offering following a successful September re-launch. BIOLIFE4D has raised more than $3M in equity crowdfunding investments since February of 2018. …
BIOLIFE4D Becomes First U.S. Company to Successfully Demonstrate Ability to 3D Bioprint a Mini Human Heart
Pioneering biotech company reaches significant milestone, using proprietary bioink to successfully 3D bioprint a mini-heart with full structure of a whole heart, including chambers and ventricles CHICAGO – September 9, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully demonstrated its…
BIOLIFE4D Launches Second Regulation A+ (Mini-IPO) Offering Due to Popular Demand
Company surpassed $2M in accepted investments during highly successful first equity crowdfunding event; expects to make significant scientific announcement in the near future CHICAGO – September 6, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its second Regulation A+…
Recent Blogs
Innovative Lab and Rich Regional Resources Help BIOLIFE4D on Way to Major Milestone
If you’ve been following along, you probably saw that last month we announced our biggest milestone to date – the ability to 3D bioprint our mini-heart. While we’ve made a lot of noise about the accomplishment (and why wouldn’t we!), we also want to showcase our amazing facilities where we were able to achieve this goal…
As Seen In Major Media: BIOLIFE4D 3D Bioprints a Mini Human Heart
If you’ve been following along, you’ll know that September was a big month for BIOLIFE4D. We re-opened our Regulation A+ equity crowdfunding campaign and then, thanks to the tremendous advancements that were made in our lab – which we’ll get to – we announced that we increased the price per share to $13.50, which represents a…
BIOLIFE4D Modifies its Regulation A+ Offering
We are excited to announce that effective today we have modified our Regulation A+ equity crowdfunding offering. As a result of the tremendous advancements we have made in our labs, the price per share will be increasing to $13.50 per share, which represents a 35% increase in share price since our original offering. Last week we…
BIOLIFE4D in the News!
BIOLIFE4D CEO Says Firm ‘One Step Closer’ to 3D Printing a Viable Human Heart
By Spencer Feingold | Oct 9 | Cheddar An Illinois-based biomedical technology firm, BIOLIFE4D, reached a watershed moment last month after successfully 3D bioprinting a miniaturized human heart. While not intended for human transplants, the mini heart was a major breakthrough in bioprinting and is expected to have broad implications for pharmaceutical testing. To Read…
A Chicago Biotech Startup’s “Mini-Heart” Could Mean Big Things for 3D Bioprinting
By Steven Ghosett, Sept. 6, 2019 “Our goal is to have this technology available to the people that need it the most and provide a life-saving option for these patients,” he said. “As with any new technology, it should be monitored so it’s not exploited for the wrong purposes.” To reach more, CLICK HERE.
BIOLIFE4D bioprints small human heart for the first time in the U.S.
By Carlota V. |Sept. 16, 2019 Dr. Ravi Birla, Chief Science Officer at BIOLIFE4D explains: “We are extremely proud of what we have accomplished, from the ability to 3D bioprint human cardiac tissue last summer to a mini heart with full structure now. We believe we are at the forefront of whole heart bioengineering, a…
BIOLIFE4D OVERVIEW
PRESS KIT
BIOLIFE4D welcomes the opportunity to speak with the media about bioprinting, its equity crowdfunding raise efforts and how building hearts will save lives.
